Skip to main content

Save up to 20% on Elsevier print and eBooks with free shipping. No promo code needed.

Save up to 20% on print and eBooks.

Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B

1st Edition, Volume 388 - September 1, 2024

Editors: Carolina Reduzzi, Lorenzo Gerratana, Massimo Cristofanilli

Language: English
Hardback ISBN:
9 7 8 - 0 - 4 4 3 - 1 3 6 5 5 - 9
eBook ISBN:
9 7 8 - 0 - 4 4 3 - 1 3 6 5 6 - 6

Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B, Volume 387 in the International Review of Cell and Molecular Biology series, highlights new advances… Read more

Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote
Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B, Volume 387 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Circulating Tumor Cells in Lung Cancer: integrating stemness and heterogeneity to improve clinical utility, Multi-omic Features and Clustering Phenotypes of Circulating Tumor Cells Associated with Metastasis and Clinical Outcomes, CTCs in CRC: updates, Proteomics and post-translational modification analysis in CTCs, Latest advances of CTC studies in prostate cancer, and Epigenetics and CTCs: new biomarkers and impact on tumor biology.